Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports

Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence shows that grading variation in daily practice is ...

Source: Diagnostic Pathology - May 11, 2020 Category: Pathology Authors: Carmen van Dooijeweert, Paul J. van Diest, Inge O. Baas, Elsken van der Wall and Ivette A. G. Deckers Tags: Research Source Type: research